Leite John 4
4 · VERACYTE, INC. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Leite John
Chief Commercial Officer-CLIA
Transactions
- Award
Common Stock
2025-03-06+36,240→ 107,660 total - Sale
Common Stock
2025-03-07$31.96/sh−5,011$160,146→ 100,249 total - Sale
Common Stock
2025-03-07$31.04/sh−2,400$74,484→ 105,260 total
Footnotes (4)
- [F1]Restricted stock units awarded on March 6, 2025 vest 25% on March 2, 2026 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
- [F2]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 6, 2024.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $30.63 to $31.61. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F4]Represents weighted average sales price. Sale prices for the transactions range from $31.71 to $32.44. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.